5-(4-Chlorophenyl)-1H-tetrazole - CAS 16687-61-9
Catalog: |
BB012329 |
Product Name: |
5-(4-Chlorophenyl)-1H-tetrazole |
CAS: |
16687-61-9 |
Synonyms: |
5-(4-chlorophenyl)-2H-tetrazole |
IUPAC Name: | 5-(4-chlorophenyl)-2H-tetrazole |
Description: | 5-(4-Chlorophenyl)-1H-tetrazole (CAS# 16687-61-9) is a useful research chemical. |
Molecular Weight: | 180.59 |
Molecular Formula: | C7H5ClN4 |
Canonical SMILES: | C1=CC(=CC=C1C2=NNN=N2)Cl |
InChI: | InChI=1S/C7H5ClN4/c8-6-3-1-5(2-4-6)7-9-11-12-10-7/h1-4H,(H,9,10,11,12) |
InChI Key: | BGKOVWIBDZMJPN-UHFFFAOYSA-N |
Boiling Point: | 356.2 °C at 760 mmHg |
Density: | 1.448 g/cm3 |
Appearance: | Solid |
MDL: | MFCD00040952 |
LogP: | 1.52010 |
GHS Hazard Statement: | H302 (88.37%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (11.63%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (11.63%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (11.63%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-108864041-A | A kind of preparation method of medicine intermediate tetrazole compound | 20180612 |
US-10577327-B2 | Pyridine based ionic fluoride for catalyzing indole and tetrazole formation | 20180611 |
WO-2019173123-A1 | Methods and compositions to reduce azoles and aox corrosion inhibitors | 20180308 |
CN-111801301-A | Methods and compositions for reducing azole and AOX corrosion inhibitors | 20180308 |
US-2020377392-A1 | Methods and compositions to reduce azoles and aox corrosion inhibitors | 20180308 |
PMID | Publication Date | Title | Journal |
21580587 | 20100303 | 5-(4-Chloro-phen-yl)-1H-tetra-zole | Acta crystallographica. Section E, Structure reports online |
18835718 | 20081101 | Inhibition of the CRM1-mediated nucleocytoplasmic transport by N-azolylacrylates: structure-activity relationship and mechanism of action | Bioorganic & medicinal chemistry |
Complexity: | 146 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 180.0202739 |
Formal Charge: | 0 |
Heavy Atom Count: | 12 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 180.0202739 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 54.5 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.8 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Triazole/Tetrazole
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS